Literature DB >> 25317631

Temporal studies into attachment, VE-cadherin perturbation, and paracellular migration of human umbilical mesenchymal stem cells across umbilical vein endothelial monolayers.

Neven A Ebrahim1, Lopa Leach.   

Abstract

Mesenchymal stem cells from Wharton's jelly of human umbilical cords (WJ-MSC) are a valuable alternate source of stem cells. Their role in situ and whether they can interact and cross intact endothelial monolayers requires elucidation. The aim of this study was to investigate the dynamic interactions between WJ-MSC and human umbilical vein endothelial cells (HUVEC), including attachment, transit times, extravasation pathway, and the effects of WJ-MSC on junctional vascular endothelial (VE)-cadherin. HUVEC were grown to near confluence in endothelial media and to full confluence in mixed media before the addition of PKH26-labelled WJ-MSC. Time lapse fluorescence microscopy showed stem cells undergoing membrane blebbing followed by amoeboid movement on HUVEC monolayers before rounding up and changing shape toward the spindle-shaped morphology during/after transmigration to subendothelial positions. Cells demonstrated a time lag of 60 min before paracellular extravasation, confirmed by confocal microscopy. Forty-six percent of attached cells crossed in the first 2 h. By 16 h, a majority of cells had transmigrated with >96% of cells crossing by 22 h. There were concomitant changes in endothelial junctional VE-cadherin with statistically significant increases in discontinuous staining at 2 h, return to control values at 16 h, even as from 22 h onward HUVEC displayed increased percentage of junctions with continuous staining and upregulation of protein. Our data suggests that WJ-MSC crosses the endothelial barrier through the paracellular pathway and can influence junctional organization of HUVEC with discreet perturbation of VE-cadherin preceding transmigration followed by upregulation once the adluminal side is reached. The latter may reflect a perivascular support function of WJ-MSC in the umbilical cord.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25317631      PMCID: PMC4313426          DOI: 10.1089/scd.2014.0207

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  24 in total

1.  Cell blebbing and membrane area homeostasis in spreading and retracting cells.

Authors:  Leann L Norman; Jan Brugués; Jan Brugés; Kheya Sengupta; Pierre Sens; Helim Aranda-Espinoza
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

2.  Mesenchymal stem cells transmigrate over the endothelial barrier.

Authors:  Annette Schmidt; Dennis Ladage; Caroline Steingen; Klara Brixius; Timo Schinköthe; Franz-Josef Klinz; Robert H G Schwinger; Uwe Mehlhorn; Wilhelm Bloch
Journal:  Eur J Cell Biol       Date:  2006-07-05       Impact factor: 4.492

3.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

4.  Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/β-catenin signaling pathway.

Authors:  Tyler Menge; Michael Gerber; Kathryn Wataha; William Reid; Sushovan Guha; Charles S Cox; Pramod Dash; Marvin S Reitz; Aarif Y Khakoo; Shibani Pati
Journal:  Stem Cells Dev       Date:  2012-06-26       Impact factor: 3.272

5.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

Review 6.  The role of adherens junctions and VE-cadherin in the control of vascular permeability.

Authors:  Elisabetta Dejana; Fabrizio Orsenigo; Maria Grazia Lampugnani
Journal:  J Cell Sci       Date:  2008-07-01       Impact factor: 5.285

7.  Distribution of mesenchymal stem cells in the area of tissue inflammation after transplantation of the cell material via different routes.

Authors:  I B Sokolova; N N Zin'kova; E V Shvedova; P V Kruglyakov; D G Polyntsev
Journal:  Bull Exp Biol Med       Date:  2007-01       Impact factor: 0.804

Review 8.  Vascular endothelial growth factors and vascular permeability.

Authors:  David O Bates
Journal:  Cardiovasc Res       Date:  2010-04-16       Impact factor: 10.787

9.  Effect of histamine on endothelial permeability and structure and adhesion molecules of the paracellular junctions of perfused human placental microvessels.

Authors:  L Leach; B M Eaton; E D Westcott; J A Firth
Journal:  Microvasc Res       Date:  1995-11       Impact factor: 3.514

10.  Study on myofibroblast differentiation in the stromal cells of Wharton's jelly: expression and localization of alpha-smooth muscle actin.

Authors:  K Kobayashi; T Kubota; T Aso
Journal:  Early Hum Dev       Date:  1998-07-10       Impact factor: 2.079

View more
  3 in total

1.  Human Vascular Wall Microfluidic Model for Preclinical Evaluation of Drug-Induced Vascular Injury.

Authors:  Erik Ersland; Neven Ebrahim; Olive Mwizerwa; Takahiro Oba; Keisuke Oku; Masafumi Nishino; Daichi Hikimoto; Hayato Miyoshi; Kimihiko Tomotoshi; Omid Rahmanian; Emmanuel Ekwueme; Craig Neville; Cathryn Sundback
Journal:  Tissue Eng Part C Methods       Date:  2022-02       Impact factor: 3.056

2.  Membrane Blebbing Is Required for Mesenchymal Precursor Migration.

Authors:  Beatriz de Lucas; Aurora Bernal; Laura M Pérez; Nuria San Martín; Beatriz G Gálvez
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

Review 3.  Human Umbilical Vein Endothelial Cells (HUVECs) Co-Culture with Osteogenic Cells: From Molecular Communication to Engineering Prevascularised Bone Grafts.

Authors:  Ievgeniia Kocherova; Artur Bryja; Paul Mozdziak; Ana Angelova Volponi; Marta Dyszkiewicz-Konwińska; Hanna Piotrowska-Kempisty; Paweł Antosik; Dorota Bukowska; Małgorzata Bruska; Dariusz Iżycki; Maciej Zabel; Michał Nowicki; Bartosz Kempisty
Journal:  J Clin Med       Date:  2019-10-03       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.